ABPA treatment references

References

Hinson KFW, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis. A review and a report of eight new cases. Thorax 1952; 7:317-333.

Campbell MJ, Clayton YM. Bronchopulmonary aspergillosis. A correlation of the clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis. Am Rev Resp Dis 1964;89:186-196.

Stark JE. Allergic pulmonary aspergillosis successfully treated with inhalations of nystatin: report of a case. Dis Chest 1967;51:96 99.

Henderson AH, Pearson JEG. Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin. Thorax 1968;23:519-23.

McCarthy DS, Simon G, Hargreave FE. The radiological appearances in allergic bronchopulmonary aspergillosis. Clin Radiol 1970;21:366 375.

Slavin RG, Million L, Cherry J. Allergic bronchopulmonary aspergillosis: characterization of antibodies and results of treatment. J Allergy 1970;46:150-5.

Crompton GK, Milne LJR. Treatment of bronchopulmonary aspergillosis with clotrimazole. Br J Dis Chest 1973;67:301-7.

Safirstein BH. Aspergilloma consequent to allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1973;108:940-943.

Safirstein BH, D’Souza MF, Simon G, Tai EHC, Pepys J. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1973;108:450-9.

Riley DJ, MacKenzie JW, Uhlman WE, Edelman NH. Allergic bronchiopulmonary aspergillosis: evidence of limited tissue invasion. Am Rev Respir Dis 1975;111:232-6.

Safirstein BH. Allergic bronchopulmonary aspergillosis with obstruction of the upper respiratory tract. Chest 1976;70:788-790.

Middleton WG, Paterson IC, Grant IWB, Douglas AC. Asthmatic pulmonary eosinophilia; a review of 65 cases. Br J Dis Chest 1977;71:115-22.

Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977;86:405-14.,

Rosenberg M, Patterson R, Roberts M, et al. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 1978;64:599-606.

Silverman M, Hobbs FDR, Gordon IRS, Carswell F. Cystic fibrosis, atopy, and airways lability. Arch Dis Child 1978;53:873-877.

Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 1979;120:863 873.

Nichols D, Dopico GA, Braun S, et al. Acute and chronic pulmonary function changes in allergic bronchopulmonary aspergillosis. Am J Med 1979;67:631-637.

Benatar SR, Keen GA, Du Toit Naude W. Aspergillus hypersensitivity in asthmatics in Cape Town. Clin Allergy 1980;10: 285–291. 

Brueton MJ, Ormerod LP, Shah KJ, Anderson CM. Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood. Arch Dis Child 1980;55:348-353.

Basich JE, Graves TS, Baz MN, et al. Allergic bronchopulmonary asergillosis in cortico-dependent asthmatics. J Allergy Clin Immunol 1981;68:98-102.

Clayton DE, Busse WW. Development of allergic bronchopulmonary aspergillosis during treatment of severe asthma with systemic corticosteroids, J Allergy Clin Immunol 1981;67:243-246.

Henry RL, Mellis CM, Simpson SJ, South RT. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Aust Paediatr J 1982;18:110-113.

Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: Staging as an aid to management. Ann Intern Med 1982;96:286-291.

Voss MJ, Bush RK, Mischler EH, Peters ME. Association of allergic bronchopulmonary aspergillosis and cystic fibrosis. J Allergy Clin Immunol 1982;69:539-546.

Birx DL, Summers R, Berger M. Acute deterioration of pulmonary function in cystic fibrosis illustrating the association of atopy and allergic bronchopulmonary aspergillosis with the underlying disease. Ann Allergy 1984;53:124-130.

Laufer P, Fink JN, Bruns WT, Unger GF, Kalbfleisch JH, Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984;73:44-48.

Schonheyder H, Jensen T, Hoiby N, Andersen P, Koch C. Frequency of Aspergillus fumigatusisolates and antibodies to Aspergillus antigens in cystic fibrosis. Acta Path Microbiol Immunol Scand. 1985;93:105-112.

Fournier EC. Trial of ketoconazole in allergic bronchopulmonary aspergillosis. Thorax 1987;42:831.

Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis: model of bronchopulmonary disease with defined serologic, radiologicm pathologic and clinical findings from asthma to fatal destructive lung disease. Chest 1987;91:Suppl:165S-171S.

Lee TM, Greenberger PA, Patterson R, Roberts M, Liotta JL. Stage V (fibrotic) allergic bronchopulmonary aspergillosis. A review of 17 cases followed from diagnosis. Arch Intern Med 1987;147:319-323.

Shale DJ, Faux JA, Lane DJ. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax 1987;42:26-31.

De Beule K, De Doncker P, Cauwenbergh G, Koster M, Legendre R,  Blatchford N, Daunas J and Chwetzoff E. The Treatment of Aspergillosis and Aspergilloma with Itraconazole, Clinical Results of an Open International Study (1982 – 1987).Mycoses 1988; 31 (9): 476-485

Forsyth KD, Hohmann AW, Martin AJ, Bradley J. IgG antibodies to Aspergillus fumigatus in cystic fibrosis: a laboratory correlate of disease asctivity. Arch Dis Child 1988;63:953-957.

Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 1988; 81:646-650.

Slavin RG, Bedrossian CW, Hutcheson PS, Pittman S, Salinas Madrigal L, Tsai CC, Gleich GJ. A pathologic study of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1988;81:718-725.

Bhargava V, Tomashefski F, Stern RC, Abramowsky R. The pathology of fungal infection and colonization in patients with cystic fibrosis. Hum Pathol 1989;20:977-986.

Currie DC, Lueck C, Milburn HJ, Harvey C, Longbottom JL, Darbyshire JH, Nunn AJ, Cole PJ. Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis. Thorax 1990;45:447-450.

Hiller EJ. Pathogenesis and management of aspergillosis in cystic fibrosis. Arch Dis Child 1990;65:397-398.

Denning DW, Van Wye J, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991; 100: 813-819.

Donnelly SC, McLaughlin H, Bredin CP. Period prevalence of allergic bronchopulmonary mycosis in a regional-hospital outpatient population in Ireland 1985-88. Ir J Med Sci 1991;160(9):288-90.

Schwartz HJ, Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 1991;117:138-142.

Germaud P, Tuchais E, Canfrere I, et al. Therapy of allergic bronchopulmonary aspergillosis with itraconazole [abstract]. Am Rev Respir Dis 1992;145:A736.

Greenberger PA, Miller TP, Roberts M, et al. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 1993;70:333-338.

Pacheco A, Martin JA, Cuevas M. Serologic response to itraconazole in allergic bronchopulmonary aspergillosis. Chest 1993;103:980-981.

Angus RM, Davies ML, Cowan MD, McSharry C, Thomson NC. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax 1994;49:586-589.

Bedi RS. Allergic bronchopulmonary aspergillosis: review of 20 cases. Indian J Chest Dis Allied Sci 1994;36:181-186.

Behera D, Guleria R, Jindal SK, Chakrabarti A, Panigrahi D. Allergic bronchopulmonary aspergillosis: a retrospective study of 35 cases. Indian J Chest Dis Allied Sci 1994;36:173-179

Chung Y, Kraut JR, Stone AM, Valaitis J. Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis. Pediatr Pulmonol 1994;17:131-134.

Greenberger PA. Diagnosis and management of allergic bronchopulmonary aspergillosis. Allergy Proc 1994;15:335-339.

Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994;105:32-36.

Panchal N, Pant C, Bhagat R, Shah A. Central bronchiectasis in allergic bronchopulmonary aspergillosis: comparative evaluation of computed tomography of the thorax with bronchography. Eur Respir J 1994;7:1290-1293.

Rothe TB, Radvila A. Spontaneous course of allergic bronchoipulmonary aspergillosis. Scheizerische Medizinische Wochenschrift 1994;124:1895-1899.

Seaton A, Seaton RA, Wightman AJ. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen year follow up. QJM 1994;87:529-537.

Caballero T, Ferrer A, Diaz Pena JM, Garcia Ara C, Pascual C, Martin Esteban M. Childhood allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1995;95:1044-1047.

Ganassini A, Cazzadori A. Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis. Respir Med 1995;89:143-145.

Germaud P, Tuchais E. Allergic bronchopulmonary aspergillosis treated with itraconazole. Chest. 1995 Mar;107(3):883.

Egan JJ, Yonan N, Carroll KB, Deiraniya AK, Webb AK, Woodcock AA. Allergic bronchopulmonary aspergillosis in lung allograft recipients. Eur Respir J 1996; 9: 69-171.

Linthoudt H, Van Raemdonck D, Lerut T, et al. The association of itraconazole and methylprednisolone may give rise to important steroid-related side effects [abstract]. J Heart Lung Transplant 1996;15:1165.

Schiraldi GF, Colombo MD, Harari S, Lo Cicero S, Ziglio G, Ferrarese M, Rossato D, Soresi E. Terbinafine in the treatment of non-immunocompromised compassionate cases of bronchopulmonary aspergillosis, Mycoses 1996;39:5-12.

Backman KS, Greenberger PA, Patterson R. Airways obstruction in patients with long-term asthma consistent with “irreversible asthma”. Chest 1997;112:1234-1240.

Fitzsimons EJ, Aris R, Patterson R. Recurrence of allergic bronchopulmonary aspergillosis in the posttransplant lungs of a cystic fibrosis patient. Chest 1997; 112:281-82. 

Panchal N, Bhagat R, Pant C, Shah A. Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir Med 1997;91:213-219.

Wojnarowski C, Eichler I, Gartner C, Gotz M, Renner S, Koller DY, Frischer T. Sensitization toAspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med 1997;155:1902-1907.

Geller DE, Kaplowitz H, Light MJ, Colin AA. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Chest. 1999 Sep;116(3):639-46.

Nepomuceno BIB, Esrig S, Moos RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 1999;115:364-370.

Salez F, Brichet A, Desurmont S, Grosbois JM, Wallaert B, Tonnel A-B. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999; 116:1665-1668.

Eaton T, Garrett MB, Milne D, et al. Allergic bronchopulmonary aspergillosis in the asthma clinic – A prospective evaluation of CT in the diagnostic algorithm. Chest 2000;118(1):66-72.

Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, Strandvik B, McKenzie SG.

Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J. 2000 Sep;16(3):464-71.

Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, Bamberger DM, Weinman AJ, Tiazpm CU, Judson MA, Platts-Mills TAE, DeGraff AC. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;11:756-762.

Al-Mobeireek AF, El-Rab MOG, Al-Hedaithy SSA, et al. Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia. Respir Med 2001;95(5):341-47.

Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002 Nov;110(5):685-92.

Skov M, Høiby N, Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy. 2002 Aug;57(8):723-8.

Suzuki K, Iwata S, Iwata H. Allergic bronchopulmonary aspergillosis in a 9-year-old boy. Eur J Pediatr. 2002 Jul;161(7):408-9.

Varshokar K. Diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. Journal of Semnan University of Medical Sciences Fall and Winter 2001-2002;3(1,2):39-45.

Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis. 2003 Oct 1;37 Suppl 3:S265-80

Tiddens HA, Pfaff SJ, van der Zanden T, Ruijgrok EJ. Weekly nebulization of liposomal amphotericine B for the treatment of prednisone dependent ABPA. Pediatr Pulmonol 2003;36(suppl 25):301.

 

Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, Simpson JL, McElduff P, Gibson PG. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol. 2003 May;111(5):952-7.

 

Casaulta C, Flückiger S, Crameri R, Blaser K, Schoeni MH. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA.

Pediatr Allergy Immunol. 2005 May;16(3):217-25.

 

Hilliard T, Edwards S, Buchdahl R, Francis J, Rosenthal M, Balfour-Lynn I, Bush A, Davies J. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros. 2005 Dec;4(4):215-20. Epub 2005 Oct 20.

 

Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest. 2006 Aug;130(2):442-8.

 

Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest.2007;132:1183–1190.

Carneiro AC, Lemos AC, Arruda SM, Santana MA. Prevalence of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis in the state of Bahia, Brazil. J Bras Pneumol. 2008 Nov;34(11):900-6. [Article in English, Portuguese]

 

Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol. 2008 Dec;43(12):1249-51.

 

Laoudi Y, Paolini JB, Grimfed A, Just J. Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA? Eur Respir J. 2008 Apr;31(4):908-9.

 

Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol. 2008 Jun;43(6):607-10.

 

Glackin L, Leen G, Elnazir B, Greally P. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Ir Med J. 2009 Jan;102(1):29.

 

Lebecque P, Leonard A, Pilette C. Omalizumab for treatment of ABPA exacerbations in CF patients. Pediatr Pulmonol. 2009 May;44(5):516.

 

Hayes D Jr, Murphy BS, Lynch JE, Feola DJ. Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis.  Pediatr Pulmonol. 2010 Nov;45(11):1145-8.

 

Howard SJ, Pasqualotto AC, Denning DW. Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis. Clin Microbiol Infect. 2010 Jun;16(6):683-8.

 

Mulliez P. [Treatment of ABPA: a place for voriconazole and omalizumab?]. Rev Mal Respir. 2010 Sep;27(7):670-2. (Article in French)

 

Pasteur MC, Bilton D, Hill AT; British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010 Jul;65 Suppl 1:i1-58.

 

Proesmans M, Vermeulen F, Vreys M, De Boeck K. Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Int J Pediatr. 2010;376287.

 

Agarwal R, Khan A, Aggarwal AN, Saikia B, Gupta D, Chakrabarti A. Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA). Intern Med. 2011;50(8):855-60.

 

          Ma Y-l, Zhang W-b, Yu B, et al. Prevalence of allergic bronchopulmonary aspergillosis in Chinese patients with bronchial asthma. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2011;34(12):909-13.

 

Chishimba L, Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma. 2012 May;49(4):423-33.

 

Collins J, Devos G, Hudes G, Rosenstreich D. Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab. J Asthma Allergy. 2012;5:65-70.

 

Elmallah MK, Hendeles L, Hamilton RG, Capen C, Schuler PM. Management of patients with cystic fibrosis and allergic bronchopulmonary aspergillosis using anti-immunoglobulin e therapy (omalizumab). J Pediatr Pharmacol Ther. 2012 Jan;17(1):88-92.

Godet C, Meurice JC, Roblot F, Kauffmann-Lacroix C, Verdaguer M, Frat JP, Cadranel J. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA. Eur Respir J. 2012 May;39(5):1261-3.

Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, Moss R, Denning DW; ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013 Aug;43(8):850-73.

 

Baxter CG, Dunn G, Jones AM, Webb K, Gore R, Richardson MD, Denning DW. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol. 2013 Sep;132(3):560-566.

Wong R, Wong M, Robinson PD, Fitzgerald DA. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis. Paediatr Respir Rev. 2013 Mar;14(1):22-4.

Chishimba L, Langridge P, Powell G, Niven RM, Denning DW. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). J Asthma. 2014 Sep 23:1-7.

Sharma VK, Raj D, Xess I, Lodha R, Kabra SK. Prevalence and risk factors for allergic bronchopulmonary aspergillosis in Indian children with cystic fibrosis. Indian Pediatr. 2014 Apr;51(4):295-7.

 

Zicari AM, Celani C, De Castro G, Valerio De Biase R, Duse M. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis. Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1839-41.